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Abstract
Background: Amyotrophic Lateral Sclerosis is characterized by a focal onset of symptoms followed by a
progressive spread of pathology that has been likened to transmission of infectious prions. Cell-to-cell transmission
of SOD1 protein aggregates is dependent on fluid-phase endocytosis pathways, although the precise molecular
mechanisms remain to be elucidated.
Results: We demonstrate in this paper that SOD1 aggregates interact with the cell surface triggering activation of Rac1
and subsequent membrane ruffling permitting aggregate uptake via stimulated macropinocytosis. In addition, other
protein aggregates, including those associated with neurodegenerative diseases (TDP-43, Httex146Q, α-synuclein) also
trigger membrane ruffling to gain entry into the cell. Aggregates are able to rupture unstructured macropinosomes to
enter the cytosol allowing propagation of aggregation to proceed.
Conclusion: Thus, we conclude that in addition to basic proteostasis mechanisms, pathways involved in the activation
of macropinocytosis are key determinants in the spread of pathology in these misfolding diseases.
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Background
The hallmark of Amyotrophic Lateral Sclerosis (ALS) is
the selective death of upper and lower motor neurons in
the motor cortex, brainstem and spinal cord, leading to
loss of voluntary muscle control, muscle atrophy and in-
variably death. The specific causes of most cases of ALS
are undefined, although approximately 10 % are inher-
ited. The best-studied familial ALS (fALS) cases are from
families possessing mutations in the gene encoding cop-
per/zinc superoxide dismutase (Cu/Zn SOD, SOD1) [1].
There is, however, a rapidly growing list of other genes
in which mutations have been implicated in fALS. These
include ALS2, SETX, FUS,VAPB, ANG, TARDBP, OPTN,
VCP, UBQLN2, PFN1, SQSTM1, and a hexanucleotide
repeat in a non-coding region of C9ORF72 [2]. Current
clinical practices are such that by the time that a diagno-
sis is confirmed disease progression is well under way
and as many as 50 % of motor units may already have
been affected [3]. There is now very strong evidence in
humans that neurodegeneration in ALS begins focally
and then spreads amongst adjacent motor neurons or
through axonal pathways throughout the three dimen-
sional anatomy of the central nervous system [4–6].
More detailed knowledge of the action of this spreading
is crucial, as is identifying a means of early detection of
the disease if we are to therapeutically slow disease
progression.
In common with other neurodegenerative diseases,
such as Alzheimer’s Disease and Parkinson’s Disease
[7, 8], there is growing evidence that disruptions to
proteostasis, protein misfolding and aggregation are
the underlying mechanisms driving neurodegeneration
in ALS [9]. Of particular interest is the fact that, al-
though nucleation of protein aggregation appears to
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be a stochastic process [10], suggesting that protein
aggregation should cause a random pattern of cell
death, cell death in ALS occurs in an ordered and
progressive manner. One way to explain such ordered
progression is the prion-like propagation of protein
misfolding and aggregation between adjacent cells. In
addition, recent work has indicated that secondary
processes, notably nucleation [11–13], takes place on
the surface of aggregates, and along with other diffu-
sional or active transport of protein aggregates be-
tween cells can give rise to cell-to-cell propagation of
the type that is often defined as prion-like behaviour.
In the specific context of ALS, previous work has
shown that exogenously applied mutant SOD1 aggre-
gates induce protein aggregation in cells overexpressing
mutant SOD1 [14]. Importantly, recent work shows that
injection of spinal cord homogenates from symptomatic
G93A SOD1 mice into the sciatic nerve of mice express-
ing G85R SOD1-YFP, below the threshold for triggering
disease, has been shown to kindle protein aggregation
and subsequent ALS-like phenotype [15]. In addition,
we have recently shown, using cell lines and primary
neurons, that propagation of SOD1 misfolding is
dependent upon the passage of misfolded SOD1 (either
mutant or wt) from cell-to-cell, a process that can be
neutralized by antibodies reactive with misfolded SOD1
epitopes [16]. We have also shown that soluble and ag-
gregated SOD1 can be taken up by neuroblastoma cells
(mouse NSC-34 and human SHSY5Y), after which it ac-
cumulates in cytosolic inclusions [17]. Clues to under-
standing the entry of aggregates into cells comes from
studies that show uptake of aggregates of SOD1 can be
blocked with EIPA, wortmannin, IPA-3 [14] and rottlerin
[16, 17], which inhibit Na+/H+ exchangers, phosphoino-
sitide 3-kinases (PI3K), P21 protein (Cdc42/Rac)-acti-
vated kinase 1 (PAK-1) and protein kinase C (PKC),
respectively (suppressing signalling events that promote
actin rearrangement and pinosome closure). These find-
ings suggest the involvement of fluid phase pinocytosis,
possibly macropinocytosis, in the aggregate uptake
process. Similarly, we have shown that cellular uptake of
soluble SOD1 can be blocked by co-treatment with EIPA
or rottlerin also suggesting that a form of pinocytosis
plays a role in this process [17].
Macropinocytosis is a form of non-selective endocyto-
sis used by cells to engulf large amounts of solute mac-
romolecules (fluid phase) or particles too large for other
forms of endocytosis. Macropinocytosis is typically de-
fined as a transient, externally induced, actin-dependent
endocytic process associated with vigorous perturba-
tions, such as ruffles and blebs, in the plasma membrane
[18]. The activation of this process results in a transient
increase in receptor-independent fluid phase endocytosis
in large vesicles or vacuoles (0.5–10 μm) termed
macropinosomes [18, 19]. Macropinosomes do not have
a coat to guide their formation and are heterogeneous in
size and shape. Macropinocytosis provides non-
phagocytic cells with the ability to take up large parti-
cles, but the process must be triggered by an external
stimulus. Bacteria, viruses, apoptotic bodies and necrotic
cells have all been shown to induce the ruffling behav-
iour typical of macropinocytosis resulting in their uptake
along with fluid [18].
There are a number of viruses, including the vaccinia
virus and adenovirus [20], that have been shown to hi-
jack macropinocytosis pathways to enter cells, including
the Japanese encephalitis virus that triggers macropino-
cytosis in neurons [21]. A lack of physical structure is
thought to result in the loss of integrity of the macropi-
nosome membrane and may explain why particles (e.g.
bacteria and virions) can escape the macropinosomes
and reach the cytosol [22]. There is emerging evidence
that prions and prion-like proteins may also enter cells
via macropinocytosis allowing the propagation of their
aggregation [14, 16, 17, 23, 24]. However, the small mol-
ecule inhibitors utilized to define macropinocytosis, such
as EIPA, are not specific to a single cellular event and
depending on the cell type can prevent various forms of
endocytosis [25].
We show here however, that aggregates of SOD1 trig-
ger activation of the Rho GTPase Rac1, leading to mem-
brane ruffling and fluid phase uptake in neurons that
defines macropinocytosis and that this facilitates aggre-
gate entry into cells. In addition, we show that these ag-
gregates can escape macropinosomes to be deposited in
the cytosol. We further show that this process is not
specific for SOD1 but rather can be triggered by a var-
iety of protein aggregates, including model protein ag-
gregates (α-lactalbumin) and those associated with
neurodegenerative diseases (TDP-43, Httex146Q and α-
synuclein). We conclude that the infectious prion-like
spread of protein aggregation in a range of neurodegen-
erative diseases is dependent on cells activating ruffling
and subsequent macropinocytosis in a manner analo-
gous to viral entry and propagation through activation of
macropinocytosis.
Results
SOD1 aggregates are taken up by cells and promote
wtSOD1 inclusion formation
We, and others, have previously shown that aggregated hu-
man SOD1 can be taken up by neuronal cells [14, 16, 17].
Here we confirm these results using recombinantly
produced properly folded and dimeric human SOD1
that was aggregated in vitro to form fibrillar structures,
as previously described [26] (Additional file 1A-B). The
preformed SOD1 aggregates were then added to the
media of the motor neuron like cell line NSC-34.
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Following incubation of the cells with the SOD1 aggre-
gates for 60 min, the aggregates could be detected in
association with the cells by flow cytometry (Fig. 1a). In
addition, human SOD1, including SDS resistant high
molecular weight (HMW) species, was detected in ly-
sates from trypsin treated cells (Fig. 1a). Furthermore,
to eliminate the possibility that SOD1 aggregates were
bound primarily to the cell surface we treated cells with
trypsin and observed no difference in SOD1 signal con-
sistent with SOD1 being inside cells (Additional file 2).
Putative uptake of SOD1 was quantified by flow cytom-
etry and it was found that soluble (properly folded)
wtSOD1 and non-aggregated ALS associated mutant
G93A SOD1 are taken up by cells to a similar extent to
that of aggregated wtSOD1 (Fig. 1b). This is consistent
with previous work showing uptake of soluble wt and
mutant SOD1 [17] and may reflect the proposed role of
non-classically secreted SOD1 in signal transduction
[27, 28]. In contrast, there was no statistically signifi-
cant increase in immunofluorescence after incubation
with an unrelated control protein GST, suggesting that
the uptake of both soluble and aggregated forms of
SOD1 is relatively specific (Fig. 1b). The uptake of ag-
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Fig. 1 Exogenously applied SOD1 aggregates enter cells and induce endogenous SOD1 aggregation. a Left panel Quantitative analysis of SOD1
association with NSC-34 cells using flow cytometry. Cells were either incubated with PBS (grey) or aggregated wtSOD1 (60 min incubation; blue line).
Right panel Western blot of cell lysates detecting human SOD1 (and actin as a loading control). (b) Left panel Association with cells was quantified using
flow cytometry. NSC-34 cells were treated with aggregated human SOD1 protein for 30 min and subsequently detected using immunofluorescence.
Results shown are means ± SE, n = 3, ** p < 0.01. Right panel Confocal laser scanning micrograph of aggregated wtSOD1 interacting with NSC34 cells
after 30 min on ice to slow endocytosis. White dotted line represents cell membrane. (c) Confocal laser scanning micrographs of biotinylated wtSOD1
aggregates incubated with NSC34 cells for 60 min then either permeabilized with Triton x-100 or not, and subsequent detection using SA-Alexa488. (d)
NSC-34 cells were transfected with wtSOD1-GFP and then incubated with either PBS, wtSOD1 (non-aggregated) or aggregated SOD1 and the number
of cells with inclusions counted at 72 h. Results shown are means ± SE, n = 3, * p < 0.05. A minimum of 150 cells were counted per treatment and the
average % of transfected cells with inclusions calculated across a minimum of 5 fields of view per treatment. (e) Cell lysates were further analyzed by
filter trap assay. Any trapped SOD1-GFP material was measured using an anti-GFP antibody to avoid measuring aggregated material added to cells.
Quantification of filter trap assays using a densitometer. Values are the mean intensity of trapped aggregated material averaged over 3
experiments. Results shown are means ± SE, n = 3, ** p < 0.01. (f) Exogenously added and endogenously produced SOD1 aggregates do
not substantively colocalise. G93A SOD1 aggregates were labelled with Alexa-633 and added to NSC-34 cells expressing wtSOD1-GFP.
After 48 h the cells were imaged using laser scanning confocal microscopy. Little colocalisation of Alexa633 and GFP signal was observed
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trypsinization of cell surface proteins prior to treatment
with aggregates significantly inhibited aggregate associ-
ation with cells (Additional file 1C). In addition, uptake
occurs relatively rapidly; SOD1 aggregates were associated
with the surface of NSC-34 cells after 30 min incubation
(Fig. 1b), and after 60 min are no longer detected on the
surface but instead are only detected following permeabil-
isation of cells with Triton X-100 (Fig. 1c).
Previous work has shown that exogenously added
preformed aggregates of mutant SOD1 containing fi-
brils can induce aggregation of intracellular SOD1 in
cells overexpressing mutant SOD1 [14], but not in
those expressing wtSOD1. Recently we have shown that
wtSOD1 can indeed participate in the propagation of
misfolded SOD1 within and between cells [16, 29]. To
further examine the induced aggregation of intracellular
wtSOD1, we transfected NSC-34 cells with wtSOD1-
GFP and added soluble or aggregated recombinant
SOD1 to the media. After 48 h of incubation there were
more cells that contained wtSOD1-GFP inclusions
when treated with aggregated SOD1 than when treated
with soluble SOD1 (Fig. 1d). As the exogenously added
aggregates were not labelled with GFP these cellular in-
clusions could not be attributed to the uptake of aggre-
gates but must have formed from intracellular wtSOD1-
GFP. The number of cells expressing wtSOD1-GFP that
spontaneously developed inclusions was low (< 1 % for
cells treated only with PBS) and occurred only in cells ex-
pressing very high levels of wtSOD1-GFP [29, 30]. As we
did not observe substantive colocalisation of the exogen-
ously applied SOD1 aggregates and SOD1-GFP, our re-
sults suggest accumulation of SOD1-GFP occurs
alongside aggregates taken up from the media (Fig. 1f).
Exogenous application of aggregated SOD1 resulted in a
highly significant (p < 0.0001) increase (from 0.85 +/−
0.42 % to 4.7 +/− 0.62 %) in the proportion of cells con-
taining inclusions (Fig. 1d). We confirmed these data
with a filter trap assay using cell lysates (Fig. 1e). In-
creased levels of SOD1-GFP were trapped on the cellu-
lose membrane when cells were treated with aggregated
wtSOD1 than those treated with soluble wtSOD1 or
PBS alone (Fig. 1e; p < 0.001). Similar results were also
seen when aggregates made from several mutant SOD1
variants that cause ALS were aggregated in vitro and
added to cells expressing wtSOD1-GFP (Additional file 3).
SOD1 aggregates escape endolysosomal system to access
the cytosol
The mechanism by which exogenously applied SOD1 ag-
gregates induce the formation of cytoplasmic inclusions
containing intracellular SOD1 likely involves the escape
of SOD1 from membrane bound endolysosomes. To test
whether SOD1 leaks from endo-lysosomal compartments
following its uptake, NSC-34 cells were incubated with
SOD1 aggregates at 37 °C and following incubation at in-
cremental time intervals co-stained for SOD1 aggregates
and lysosomes. Exogenous SOD1 aggregates co-localised
with Lysotracker (fluorescent in mildly acidic compart-
ments) until 30 min, after which low levels of SOD1 could
be observed outside the acidic endo-lysosomal system
(Fig. 2a). To determine if SOD1 aggregates had entered
the cytosol we first performed sub-cellular fractionation of
cells. Immunoblotting of cytosolic, membrane (ER/Golgi),
nuclear and cytoskeletal fractions demonstrated that ag-
gregated SOD1 predominantly fractionated with the cyto-
skeleton fraction (Fig. 2b). We observe upon boiling in
SDS that the aggregates no longer appear as high molecu-
lar weight species stuck in the loading gel (see Fig. 1a), but
are reduced to apparent cross-linked species as previously
observed [31]. These results are consistent with SOD1 ag-
gregates having a density comparable to cytoskeleton ele-
ments and, in addition, suggests cytosolic exposure of
SOD1 aggregates. There was also a very small amount of
high molecular weight SOD1 observed in the nuclear frac-
tion, again consistent with cytosolic exposure (outside of
the endo-lysosome system). However, in confocal micros-
copy experiments aggregates were not observed within
the nucleus (Fig. 2d) suggesting aggregated material either
bound the nuclear membrane or pelleted at a similar
density to the nuclear fraction.
To confirm that aggregates were present outside any
membrane enclosed compartments we used selective
permeabilization; Triton- X-100 disrupts all cellular mem-
branes, while digitonin permeabilizes only the plasma
membrane [32] (see also control membrane enclosed
[Lysosomal associated membrane protein 1; LAMP1,
Binding immunoglobulin protein; BiP, Early endosome
antigen 1; EEA1] and cytosolic proteins shown in Fig. 2c).
After 60 min incubation, human SOD1 aggregates were
detected only after Triton X-100 permeabilization (Fig. 2d).
However, after 120 min, SOD1 aggregates could also be
detected after permeabilization by digitonin, consistent
with aggregate presence in the cytosol. Soluble human
SOD1 was also able to escape the endosome system, such
that it was detected in the cytosol after digitonin
permeabilization (Additional file 4). In contrast, when the
control protein RAP-GST (known to be internalized by
receptor mediated endocytosis) was added to cells for
120 min it was not detected after digitonin permeabliza-
tion (Additional file 4), consistent with its retention in an
endosomal-lysosomal compartment.
Macropinosomes are thought to be ‘leaky’ due to their
lack of physical structure [22]. In order to test the possi-
bility that SOD1 aggregates are rupturing macropino-
somes we specifically permeabilized only the plasma
membrane with digitonin and then stained for galectin-3
after 2 h of incubation with SOD1 aggregates. Galectin-3
is a non-classically secreted β-galactoside binding lectin
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that has been shown to be enriched in Rab positive
endosomes [33] and also redistributes from the cytosol to
endosome fragments upon endosome rupture [34, 35].
We utilized our selective permeabilization method (see
Fig. 2c) to examine increased cytosolic exposure of
galectin-3 indicating rupture of endosomal compartments.
Cells permeabilized by digitonin and treated with PBS
alone showed very little galectin-3 staining compared to
cells permeabilized with Triton x-100 (Fig. 3), consistent
with a large fraction of galectin-3 being located on the in-
side endosomal compartments [33] in NSC-34 cells. Com-
pared to controls, the cultures treated with misfolded
G93A SOD1 or aggregated SOD1 contained an increase
in staining for galectin-3 indicative of endosome rupture
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Fig. 2 Internalized aggregates entering via the endocytic pathway escape from the endosomes to the cytosol. a Confocal microscopy of the co-staining
of wtSOD1 aggregates (20 μg/mL) taken up by NSC-34 cells after 10, 30 and 60 min at 37 °C, with Lysotracker Red. Fixed and permeabilized cells were
immunostained with an anti-human specific SOD1 antibody. Bars represent 25 μm. Arrowheads indicate areas of localisation of SOD1 outside the acidic
compartment. (b) Western blotting of cytosolic, membrane (ER/Golgi), nuclear and cytoskeleton fractions (10 μg) collected from NSC-34 cells treated with
wtSOD1 aggregates (20 μg/mL) for 2 h at 37 °C. Western blots were stained for the presence of human SOD1, EEA1, actin and vimentin. (c) Digitonin
selectively permeabilizes plasma membrane of NSC-34 cells. NSC-34 Cells were treated with either digitonin (10 μM) or Triton-x100 (0.5 %) and then
immunostained for membrane bounded markers LAMP1, BIP and EEA and the cytosolic β-tubulin. Membrane bounded markers were not detected
when permeabilized with digitonin indicating the specificity of digitonin for plasma membrane. Cells were counterstained with Red Dot 2. (d) Laser
scanning confocal micrographs of NSC-34 cells were treated with aggregated human SOD1 protein for 60 or 120 min then fixed and permeabilized
with either Triton-x100 (0.5 %) or digitonin (10 μM). SOD1 aggregates were detected using Alexa488 conjugated to streptavidin and counter stained
with the nuclear dye Red Dot 2. SOD1 aggregates are only detected upon digitonin permeabilization after 120 min SOD1 incubation. White dotted line
represents cell membrane
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and exposure of galectin-3 (Fig. 3). In addition, we treated
human red blood cells with the SOD1 samples and the
amount of membrane disruption was measured by free
hemoglobin (Additional file 5A). Soluble mutant G93A
SOD1, and aggregated SOD1 increased the amount of free
hemoglobin consistent with an ability to damage bio-
logical membranes (Additional file 5A). Lastly, we gener-
ated unilamellar vesicles and examined for interaction of
SOD1 aggregates. Similar to previous findings for fibrillar
aggregates [36], aggregates of SOD1 interacted with lipo-
somes and deformed their structure (Additional file 5B).
Together, these data are consistent with SOD1 aggregates
disrupting biological membranes and escaping in to the
cytosol.
Aggregated SOD1 triggers ruffling and subsequent
macropinocytosis in neurons
Previous studies have shown that small molecules that in-
hibit actin rearrangement, or Na+/H+ exchangers, Pak-1,
PI3K, and PKC suppress aggregate uptake [14, 16, 17], con-
sistent with macropinocytosis. However, it has not been
shown whether macropinocytosis is triggered through an
interaction of SOD1 with cells or whether aggregates are
taken up by some other constitutive process. Initially, we
used EIPA (an inhibitor of the Na+/H+ exchanger and sub-
sequent endocytosis) and rottlerin (an inhibitor of PKC), as
reported previously [14, 16, 17], to confirm the involvement
of macropinocytosis-like pathways in the uptake of SOD1
aggregates into NSC-34 cells. Aggregate uptake was inhib-
ited by both EIPA and rottlerin (p < 0.001; Fig. 4a-b), how-
ever inhibitors of clathrin (chlorpromazine) or caveolin
(genistein) dependent endocytosis had no significant effect
on this process (Fig. 4a-b). Macropinocytosis is a form of
fluid phase endocytosis that engulfs solutes at whatever
concentrations they are found in the extracellular medium,
rather than concentrating ligands at the cell surface. EIPA,
cytochalasin D (an inhibitor of actin rearrangement) and
rottlerin inhibited fluid phase uptake (quantified as
dextran-Alexa647 uptake) stimulated by phorbol 12-
myristate 13-acetate (PMA) treatment of NSC-34 cells,
but genistein and chlorpromazine did not, demonstrating
the specificity of the inhibitors to PKC-dependent fluid
phase uptake (Additional file 6A). Similar results were
found regardless of whether or not the aggregates were wt
or mutant G93A SOD1 (Additional file 6B). While a simi-
lar pattern of SOD1 uptake inhibition was found when sol-
uble non-aggregated wtSOD1 was applied to cells (largest
decreases in fluorescence when co-incubated with EIPA
and rottlerin; Additional file 6C), non-aggregated G93A
SOD1 uptake was inhibited by similar levels regardless of
the inhibitor used (Additional file 6D).
We next investigated whether there were any pertur-
bations to the cell surface membrane caused by incuba-
tion with SOD1. Field emission scanning electron
microscopy (FESEM) imaging of cells treated with PMA
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Treatment
Fig. 3 Endosome rupture by SOD1 aggregates. NSC-34 cells were incubated with either PBS (digitonin and Triton X-100 treatments), non-aggregated
wt or G93A SOD1 or aggregated G93A SOD1 for 2 h before permeabilizatin (digitonin for the SOD1 treatments), fixation, immunostaining of galectin-3
and the mean fluorescence per cell quantified. A minimum of 150 cells were counted per treatment across a minimum of 5 fields of view per
treatment and the mean galectin-3 fluorescence per cell calculated. Results shown are means ± SE, ** p < 0.01, *** p <0.001. Confocal microscopy of
the immunostaining of galectin-3 after treatment with PBS and the SOD1 preparations, counterstained with RedDot
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ruffles and blebs (Fig. 5a), consistent with an activation
of macropinocytosis. Incubation with soluble G93A
SOD1 did not induce such perturbations, although incu-
bation with aggregated G93A SOD1 induced pro-
nounced membrane ruffling and blebbing consistent
with macropinosome formation (Fig. 5a). To exclude the
possibility that cells were blebbing due to apoptosis, we
examined the cells for active caspase 3, however there
was no caspase 3 activation in cells treated with aggre-
gates above basal (PBS treated) levels (Additional file 7).
To visualize and quantify the extent of membrane per-
turbation we used the membrane dye FM® 1-43FX, as
used previously for studies of membrane perturbation
during growth cone ruffling [37]. Fluorescence from FM
1-43FX was significantly increased (p < 0.001) upon
treatment of cells with SOD1 aggregates, consistent with
an increase in membrane perturbation (Fig. 5b). In con-
trast, there was no increase in fluorescence following in-
cubation with soluble SOD1 (Fig. 5b).
Next, to explore whether the interaction of SOD1 ag-
gregates with cells triggers fluid phase uptake, we incu-
bated NSC-34 cells in the presence of both SOD1 and
dextran-Alexa647 and quantified uptake of the latter
using flow cytometry. Aggregated SOD1 triggered a sig-
nificant increase (p < 0.001) in dextran uptake compared
to that in the absence of treatment or following incuba-
tion with soluble SOD1 (Fig. 5c). Whilst there was a
small increase in dextran uptake in cells treated with sol-
uble SOD1 compared to those not treated (Fig. 5c) this
was thus not attributable to stimulated macropinocytosis
as it occurred in the absence of membrane ruffling
(Fig. 5a). Finally, we examined the role of the Rho
GTPase, Rac1, in the uptake of SOD1 aggregates. Ini-
tially we probed for the presence of activated Rac1 using
an ELISA based assay. Incubation of cells with aggre-
gated but not with soluble SOD1 resulted in a significant
increase (p < 0.05) in the amount of activated Rac1
(Rac1-GTP; Fig. 5d) in NSC-34 cells. In addition, the
uptake of SOD1 aggregates was significantly suppressed
(p < 0.001) by pre-treatment and subsequent co-incubation
of aggregates with the Rac1 inhibitor W56 (Fig. 5e). To
confirm that Rac1 was downstream of membrane ruffling
we treated cells with PMA or SOD1 aggregates in the
presence or absence of W56 and then examined for mem-
brane perturbations using FM1-43FX. We observed that
in the case of both PMA and aggregate treated cells W56
suppressed membrane perturbation (Additional file 8).
We also used human iPSC-derived motor neuron cul-
tures to determine whether or not these effects are also
observed in human neurons (differentiation character-
ized in Additional file 9). The motor neuron cultures
contained 90.5 ± 1.4 % SMI32-positive cells and 88.8 ±
1.4 % Islet 1-positive cells, with large cell bodies, consist-
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Fig. 4 Rottlerin and EIPA treatment inhibits the uptake of SOD1
aggregates. a-b Internalization of aggregated wtSOD1 (20 μg/mL) after
30 min at 37 °C, in the absence (no treatment; NT) or presence of
a pre-incubation step with either rottlerin (Rot; 3 μM) a PAK-1 and
PKC inhibitor, EIPA (100 μM) a Na+/H+ exchange inhibitor, genistein
(Gen; 10 μM) a caveolin mediated uptake inhibitor, or chlorpromazine
hydrochloride (CPZ; 5 mM) a clathrin mediated endocytosis inhibitor. a
The mean fluorescence intensity (MFI) of SOD1 aggregate uptake was
determined by flow cytometry. Results shown are means ± SD, n =6,
*** P <0.001 (b) Laser scanning confocal micrographs of aggregated
wtSOD1 internalized by NSC-34 cells in the presence or absence of a
pre-incubation step with rottlerin (Rot), EIPA, genistein (Gen) and
chlorpromazine hydrochloride (CPZ)
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Fig. 5 (See legend on next page.)
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neuron morphology (Additional file 10). Treatment of
human motor neuron cultures with aggregated SOD1
promoted membrane perturbations, such as ruffling and
blebbing (Fig. 6 arrowheads). This membrane perturb-
ation, quantified with the membrane dye FM1-43, was
significantly increased compared to cells treated with
PBS alone and similar to that induced by PMA (Fig. 7a-b,
Additional file 11B). Furthermore, human neurons treated
with SOD1 aggregates exhibited an increase in fluid phase
uptake (Fig. 7c-d, Additional file 11A). Lastly, as ob-
served for NSC-34 cells, the uptake of SOD1 aggregates
into neurons was suppressed by the Na+/H+ exchanger
inhibitor, EIPA (Fig. 7e, Additional file 11C), the inhibi-
tor of PKC, rottlerin (Fig. 7f, Additional file 11C) and
the Rac1 inhibitor, W56 (Fig. 7g, Additional file 11C).
Activation of membrane ruffling is not restricted to SOD1
aggregates
Given that SOD1 aggregates were found to trigger the
activation of membrane ruffling and entry via macropi-
nocytosis, we sought to determine if triggering of mem-
brane ruffling was responsible for a generic cellular
response to aggregates. We therefore examined the up-
take of disease-associated fibrillar aggregates formed by
TDP-43, Httex1-46Q, α-synuclein, and also of amorphous
and fibrillar aggregates formed from the model protein
α-lactalbumin [38] into NSC-34 cells (Fig. 8, Additional
file 12). Using laser scanning confocal microscopy we
confirmed the uptake of aggregates in each case (Fig. 8a)
and, with the exception of α-synuclein, the levels of up-
take were significantly suppressed by EIPA (Fig. 8a-b).
PBS G93A SOD1 Agg. PMA
10 μm
20 μm
Fig. 6 Aggregated SOD1 induces membrane ruffling in iPSC derived human motor neurons. Field emission SEM of motor neurons treated with
SOD1 aggregates, and PBS or PMA controls. The area in the dashed box is enlarged in the bottom panels. Increases in membrane perturbations
can be observed, such as ruffles and blebs (white arrow heads). Bars represent 20 μm in top row and 10 μm in the bottom row. Data shown is
from experiments performed on cells derived from one fibroblast line and represents experiments performed on cells from 2 individuals
(See figure on previous page.)
Fig. 5 Aggregated SOD1 induces ruffles and blebs, dextran uptake and activation of RAC1. a Field emission SEM of cells treated with SOD1
aggregates or controls, non-aggregated SOD1 (sol SOD1), PMA or PBS (untreated). Increases in membrane perturbations can be observed, such as
ruffles (black arrow) and blebs (black arrow head). Bars represent 2 μm. (b) Laser scanning confocal micrographs of treated cells stained with the
membrane dye FM1-43FX to measure membrane perturbation and fluorescence intensity per cell was quantified using ImageJ. Scale bars represent
20 μm. A minimum of 200 cells were scored per treatment. Results shown are means ± SD of three experiments, * p < 0.05 ** p < 0.01. (c) The induction
of fluid phase uptake was measured using fluorescently labelled dextran. Laser scanning confocal micrographs of dextran-Alexa647 uptake in treated
NSC-34 cells. Outline of cells are indicated with white dashed lines. Scale bars represent 20 μm. (e) Flow cytometry quantification of dextran uptake in
the treated NSC-34 cells. Results shown as means ± SD of 6 experiments * p <0.05 ** p < 0.01. (d) Rac1 activation in treated NSC-34 cell lysates was
measured using a Rac1 activation ELISA assay that probes for Rac1-GDP. Results are mean ± SD of 6 experiments, ** p < 0.01. (e) Addition of a Rac1
inhibitor reduces SOD1 uptake. Laser scanning confocal micrographs of SOD1 aggregate uptake in the presence of absence of W56, mean fluorescence
per cell was calculated using ImageJ. Data are mean fluorescence intensity per cell of a minimum of 100 cells ± SD, p < 0.001
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Moreover, all aggregates induced a significant (p < 0.01)
increase in the uptake of the fluid phase marker
dextran-Alexa647 (Fig. 8c) and an increase in membrane
perturbations, as illustrated in FESEM images (Fig. 8d).
Thus, a broad range of aggregated proteins, both amorph-
ous and amyloid-like, are able to induce membrane per-
turbations that facilitate their cellular uptake in a similar
manner to that of SOD1 (Fig. 8).
Discussion
The work presented here reveals that both soluble
and aggregated SOD1 are taken up by neuronal cells
via fluid phase endocytosis pathways. In addition we
show that aggregated but not soluble SOD1 triggers
activation of Rac1 and subsequent membrane ruffling,
and thus itself stimulates macropinocytosis, not only
in cell lines but also in human iPSC derived motor
neurons. This process differs from that responsible
for the uptake of soluble SOD1, which is independent
of membrane ruffling and occurs presumably via a
constitutive form of pinocytosis in the case of the
wtSOD1 and potentially via a range of mechanisms in
the case of soluble G93A SOD1. SOD1 aggregates are
not permanently maintained in a membrane bound
compartment once inside the cells, but rupture macropi-
nosomes and escape into the cytosol where they can in-
duce further aggregation. In addition, the data presented
here shows that other protein aggregates, including those
of TDP-43, Httex1-46Q, α-synuclein, and α-lactalbumin,
can also trigger significant perturbations in the plasma
membrane of neurons allowing the uptake of large fibrillar
or amorphous protein aggregates.
Various viruses, such as the vaccinia virus, adenovirus
3, herpes simplex virus 1 and HIV, utilize macropinocy-
tosis to gain entry to cells. This phenomenon is likely to
be due to the fact that macropinosomes are not re-
stricted in size, enabling even large virions to be inter-
nalized, and that many cell types, not just professional
phagocytes (such as macrophages), have the ability to ac-
tivate the macropinocytosis pathways [18]. Indeed,
macropinocytosis can be activated in neurons by interac-
tions with large viral particles [21]. In the specific con-
text of ALS we show that aggregates formed by SOD1
can activate the same macropinocytosis pathways as
those utilized by virions and that this can result in the
propagation of aggregation. In addition, we show that
aggregates formed from TDP-43, which are also asso-






















































































































































































Fig. 7 SOD1 aggregates activate membrane perturbation and dextran uptake in iPSC derived human motor neurons. Laser scanning confocal
micrographs of treated cells stained with the membrane dye FM1-43FX (a) to measure membrane perturbation and fluorescence intensity quantification
using ImageJ (b). A minimum of 100 cells were scored per treatment. Results shown are means ± SD of three experiments, * p < 0.05 ** p < 0.01. The
induction of fluid phase uptake was measured using fluorescently labelled dextran. (c) Laser scanning confocal micrographs of dextran-Alexa647
uptake in treated motor neurons. (d) ImageJ quantification of dextran uptake in the treated motor neurons. A minimum of 100 cells per treatment were
scored. Results shown as means ± SD of 3 experiments * p <0.05 ** p < 0.01. (e) Laser scanning confocal micrographs of aggregated SOD1
internalized by motor neurons in the presence or absence of a pre-incubation step with macropinocytosis inhibitors EIPA (e), Rottlerin (f) and rac1
inhibitor W56 (g). Fluorescence was quantified by imageJ. Data are mean fluorescence intensity per cell of a minimum of 100 cells ± SD, p < 0.001. Data
shown is from experiments performed on cells derived from one fibroblast line and represents experiments performed on cells from 2 individuals
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subsequent cellular uptake. Previous work has shown
that amyloid fibrils can enhance HIV viral infection
[39], it is interesting to speculate that this behaviour
could be due to the potent ability of such aggregates
to stimulate macropinocytosis.
Our data are consistent with the notion that protein
aggregates could be an active part of ALS disease pro-
gression, possibly through secondary nucleation [40], or
another prion-like aggregate propagation process. Recent
work provides striking evidence that this may indeed
Htt 46Q α-lac A α-lac RCM



































































































































Fig. 8 Other aggregated proteins are capable of stimulating plasma membrane ruffling (a) Laser scanning confocal micrographs of uptake of
TDP-43, Httex146Q, α-synuclein, and α-lactalbumin aggregates into NSC-34 cells. Cells were incubated with the aggregated proteins (20 μg/mL) in
the presence or absence of EIPA. Fixed and permealized cells were labelled with an ALEXA-488 conjugated to SA (green) and RedDot 2 (red).
(b) ImageJ quantification of SOD1 uptake in to treated NSC-34 cells. Results shown as mean fluorescence intensity per cell, minimum 50 cells,
± SD, ** p < 0.01. (c) Flow cytometry of NSC-34 cells co-treated with protein aggregates and dextran-Alexa647. Results shown as means ± SD, n =3,
*** P <0.001. (d) Field emission SEM of cells treated with protein aggregates
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drive disease progression as focal injection of spinal cord
homogenates from symptomatic G93A SOD1 triggers
progressive motor neuron disease in mice expressing
G85R SOD1-YFP below the threshold for disease [15].
Our data however, does not directly demonstrate seeding
of aggregation and as such we cannot rule out the possi-
bility that the stress of aggregate uptake induces further
aggregation in the absence of seeding. We have also
shown that Rac1 and protein kinase C (PKC) pathways
are actively involved in aggregate uptake. Interestingly,
intracellular mutant SOD1 has been found to interact
with and activate Rac1 [41]. Rac1, a Rho GTPase, has
been identified as an important and central player in
triggering membrane ruffles associated with virus entry
into cells and has been found to do so by activating
downstream effectors of actin polymerisation [42]. In
addition, while the precise role of PKC in virus entry is
still unclear, its activation with PMA (as used in this
study) can induce ruffling and fluid uptake in the ab-
sence of ligands that bind the cell surface [43].
There is a growing wave of evidence that is consistent
with the hypothesis that protein aggregates propagate
between cells and that this is responsible for the orderly
progression of disease pathology seen in some neuro-
logical disorders [44–49]. The most startling evidence
shows that healthy cells grafted into the brains of people
with Parkinson’s disease acquires intracellular inclusions
of α-synuclein, known as Lewy bodies [47]. Evidence
suggests that large fibrillar aggregates of a range of pro-
teins (tau, α-synuclein, and expanded polyglutamine
repeats) are able to gain access to the cytoplasmic com-
partment via an incompletely understood mechanism
and induce protein aggregation [44, 45, 48, 49]. We
show here that aggregates of proteins associated with
ALS, Parkinson’s and Huntington’s disease all trigger
both membrane ruffling and fluid uptake; findings indi-
cating the stimulation of macropinocytosis.
While much of the focus on toxic aggregate species
has been placed on oligomers, our data adds to work
already published that demonstrates large insoluble ag-
gregates can be taken up by cells and subsequently pro-
mote propagation of aggregation [16, 23, 44–49]. It has
previously been shown that aggregation of α-synuclein
can be triggered in an acidic environment and that this,
through secondary nucleation, may produce a range of
aggregates including toxic oligomers [40]. Taken to-
gether, these data suggest that the propagation of large
insoluble aggregates through cellular uptake may be re-
sponsible for the perpetual propagation and generation
of toxic oligomeric species. This conclusion, together
with the knowledge of intracellular pathways that result
in macropinosome formation and closure, provide pos-
sible therapeutic targets for halting the propagation of
aggregation in these disorders. For example, we have
previously shown that microglia recognize protein aggre-
gates through CD14, scavenger and toll-like receptors,
and hence may use receptor-mediated endocytosis, ra-
ther than macropinocytosis, to facilitate the uptake of
aggregates and to promote their degradation [50, 51].
This distinction between microglia and neurons provides




The mouse neuroblastoma x spinal cord hybrid cell line
(NSC-34 cells [52]) were routinely cultured in DMEM/
F12 supplemented with 10 % (v/v) FBS and 2 mM Gluta-
MAX. Cells were maintained in an incubator at 37 °C
under a humidified atmosphere containing 5 % (v/v)
CO2. Human fibroblasts were sourced from non-ALS in-
dividuals (female aged 62 and male aged 59 at the time
of collection) and reprogrammed into induced pluripo-
tent stem cells using mRNA (Miltenyi). Pluripotency
was confirmed by PluriTest and differentiation of the
cells [53]. Karyotyping was carried out in iPSCs, to en-
sure chromosomal abnormalities were not introduced
during reprogramming and culture. Immunocytochem-
istry confirmed the expression of the pluripotency
marker Oct4 (Additional file 9A).
Differentiation of pluripotent stem cells into motor
neurons was carried out as in [54] and one clone from
each line was used in experiments. Motor neurons
(150,000 cells) were plated onto laminin (20 μg/mL) and
fibronectin (10 μg/mL) coated 13 mm coverslips. The
timeline summarizes the differentiation stages and the
growth factor conditions used during differentiation
(Additional file 9B). The morphological changes of each
cell line were examined at each stage of the differenti-
ation process (Additional file 9B).
Confirmation of motor neuron phenotype was carried
out, including expression analysis by quantitative reverse
transcription PCR and immunocytochemistry. The dif-
ferentiated neurons expressed the motor neuron specific
markers SMI32 and islet 1 (Additional file 9C). Im-
munocytochemistry identified the presence of extended
dendrites ~100 μm in length. Quantitative reverse tran-
scription PCR analysis identified the expression of the
motor neuron specific gene MNX1 (that encodes the
transcription factor homeobox 9, HB9) [55]. MNX1 was
specifically expressed in motor neurons and MNX1 was
silent in pluripotent stem cells. The cholinergic specific
marker acetylcholine esterase (ACHE that encodes the
enzyme responsible for the degradation of the neuro-
transmitter acetylcholine) was specifically expressed in
cholinergic motor neurons. The expression levels for
both MNX1 and ACHE, were normalized to the house-
keeper gene GAPDH (Additional file 8D).
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Application of aggregates to cells
Wt and G93A SOD1 were expressed and purified from
E.coli as previously outlined [50, 56]. SOD1 aggregation
was performed in vitro as previously described [50].
Briefly, solutions of purified wt or G93A mutant SOD1
protein (1 mg/mL) in PBS were co-incubated with
20 mM dithiothreitol (DTT) and 5 mM ethylenedi-
aminetetraacetic acid (EDTA) for 72 h at 37 °C with
shaking; aggregated SOD1 was washed several times to
remove DTT and EDTA. NSC-34 cells were cultured in
12 well plates and were transfected with wt or mutant
SOD1-GFP using lipofectamine 2000 (following the
manufacturer’s instructions). Lipofectamine was re-
moved after 5 h and replaced with 10 % FCS in DMEM.
After 24 h the aggregates, or soluble (non-aggregated)
wtSOD1 as a control, were added in fresh media to
transfected or naïve NSC-34 cells. Cells were incubated
for a further 48 h and then imaged. In other experi-
ments, aggregates were added to untransfected NSC-34
cells and incubated for various time periods in the pres-
ence or absence of pathway inhibitors before fixation
and detection of aggregates (see online methods for de-
tails). In some experiments, NSC34 cells were incubated
with 20 μg/mL of human wt and mutant SOD1 aggre-
gates for 1 h at 37 °C. Post incubation, cells were washed
three times in PBS and incubated with trypsin (0.25 %,
Invitrogen) for 5 min to remove surface-bound aggregates.
The resulting detached cells were centrifuged at 1100 × g
for 5 min, re-plated in media, and allowed to recover for
6 h at 37 °C before fixation for immunocytochemistry.
Aggregation and biotinylation of wt and G93A SOD1
aggregates
SOD1 aggregation was performed in vitro as previously
described 50. Aggregated SOD1 was labelled with biotina-
midohexanoic acid 3-sulfo-N-hydroxysuccinimide ester
sodium salt in DMSO for 2 h at RT. The unconjugated
biotin was then separated by centrifugation (21 000 x g for
30 min) and washed three times with PBS. The purified
aggregates were then resuspended in PBS (pH 7.4). A
bicinchoninic acid protein assay was performed to deter-
mine the amount of protein in solution. Aggregated forms
of other proteins were obtained by incubation under
conditions previously described, Httex146Q [57] , TDP-43
[58], α-synuclein [59], and α-lactalbumin [38].
Cell surface binding and internalization of aggregated
SOD1
NSC-34 cells were initially incubated with 20 μg/mL of
aggregated SOD1 for 30 min at 4 °C. Cells were then
fixed with 4 % (w/v) paraformaldehyde (PFA) in PBS
(pH 7.4) before immunodetection. In separate experi-
ments, cells were incubated with 20 μg/mL of aggre-
gated wtSOD1 for 60 min at 4 °C, fixed with 4 % (w/v)
PFA in PBS (pH 7.4) and permeabilized, or not, with Tri-
ton x-100. SOD1 was then detected using anti-SOD1 anti-
bodies. Cells were imaged using a Leica TCS SPII laser
scanning confocal microscope (Heidelberg, Germany). In
addition, quantitative analysis of SOD1 internalisation into
NSC-34 cells was performed using flow cytometry using a
BD LSRII (California, USA). Cells were incubated with
20 μg/mL of aggregated SOD1 for 60 min at 4 °C. Cells in-
cubated with PBS (pH 7.4) alone acted as the control.
Similar experiments were performed in the presence of
the dye, Lysotracker Red as per the manufacturer’s
instructions. In addition, some cells were treated with
trypsin and washed extensively before being lysed after in-
cubation with aggregated wtSOD1 for 60 min. The cell ly-
sates were analysed by Western blotting.
Internalisation of aggregated SOD1 was measured in
the presence or absence of a range of compounds that
inhibit various internalisation mechanisms. NSC34 cells
were pre-treated with various endocytic inhibitors in-
cluding 100 μM 5-N-ethyl-N-isopropyl-amiloride (EIPA),
5 μM chlorpromazine hydrochloride (CPZ), 10 μM ge-
nistein (Gen) or 3 μM rottlerin (Rot) diluted in 1 %
BSA/PBS for 30 min at 37 °C, followed by 20 μg/mL ag-
gregated wtSOD1 for 30 min at 37 °C. Cells were then
fixed and permeabilized before detection of biotinylated
aggregates with SA- Alexa 488. Cells were washed once
with PBS medium and analysed using a LSR II flow cyt-
ometer (BD Biosciences, San Diego, CA) (excitation
488 nm, emission collected with 515 ± 20 band-pass fil-
ters). The mean fluorescence intensity (MFI) of relative
SOD1 uptake was determined using FlowJo software
(Tree Star, Ashland, OR). For confocal microscopy, cells
remained on glass coverslips and incubated in wells as
outlined for flow cytometry. Sytox Red (5 nM) was used
as a counter stain. Results are the average of at least five
independent experiments.
Field emission scanning electron microscopy (FESEM)
NSC-34 cells in phenol-red serum free culture medium
were plated into 12-well plates with 19 mm glass cover-
slips (7x104 cells/ ml/well) and starved of serum for
24 h, and treated with 20 μg/mL soluble or aggregated
proteins in PBS or PBS containing 200 nM PMA for 2 h
at 37 °C. Post incubation, cells were washed three times
in PBS then fixed in 2.5 % glutaraldehyde/ 4 % PFA in
0.1 M phosphate buffer (pH 7.4) for 3 h at 4 °C. The
cells were then washed three times in phosphate buffer
and postfixed in 2 % OsO4/ water at RT for 1 h. After
washing with water, the cells were dehydrated using a
gradient of ethanol at 30, 50, 70, 80, 90 and 100 %
(30 min per incubation) at RT. The cells were then crit-
ical point dried for 2 h using a LEICA CPD030 (Vienna,
Austria) and coated with graphite-gold in a sputter
coater. The samples were analysed with a JEOL 6490LV
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SEM (Tokyo, Japan) operated at 10 kV at a 10 mm
working distance and a spot size setting of 35.
Rac1 activation assays
NSC-34 cells were treated with 20 μg/mL of soluble and
aggregated G93A SOD1 for 30 min at 37 °C. The cells
were washed twice with cold PBS and harvested by treat-
ment with 0.05 % trypsin for 10 min at 37 °C. Rac1 acti-
vation was measured using a G-LISA activation kit (Kit
#BK128 Cytoskeleton, Inc. (Denver, USA) as per the
manufacturer’s recommendations.
Transmission electron microscopy
Negative staining was performed using substrate carbon-
coated nickel grids (Proscitech Kirwan, Australia). Pro-
tein was loaded onto the grid and washed three times
with milli-Q water. Subsequently, 2 % (w/v) uranyl acet-
ate (ProsciTech Kirwan, Australia) in 0.22 μm sterile fil-
tered milli Q water was added for 2 min to stain the
proteins negatively. The grids were analysed using a JEOL
2011 TEM (Tokyo, Japan) operated at 200 kV and Images
taken using a Gatan Orius digital camera (California,
USA).
Pharmacological inhibitors and antibodies
Pharmacological inhibitors were prepared in either
DMSO or 20 % acetonitrile/water according to the man-
ufacturer’s recommendations and used at the indicated
concentrations. EIPA, CPZ, Gen, and Rot were pur-
chased from Sigma Aldrich. The Rac1 inhibitor W56
was purchased from Tocris Bioscience.
Specific antibodies including mouse anti-beta actin
(ab8226), rabbit anti-EEA1 antibody (ab2900), Anti-
LAMP1 [H4A3], anti-beta actin antibody [AC-15], anti-
beta tubulin antibody, anti-neuron specific beta III
tubulin were purchased from Abcam. Alexa Fluor 488
goat anti-mouse, Alexa Fluor 488 goat anti-rabbit,
streptavidin Alexa Fluor 633 conjugate, streptavidin
Alexa Fluor 488 conjugate, Alexa Fluor 488 donkey
anti-sheep, Alexa Fluor 488 donkey anti-rabbit, SYTOX
Red dead cell stain, FM® 1-43FX fixable analogue of
FM® 1–43 membrane stain were purchased from Invi-
trogen Life Technologies. Donkey anti-sheep/goat IgG
HRP conjugate and goat anti-mouse IgM + IgG + IgA
(H + L) HRP conjugates were purchased from Millipore.
Sheep anti-SOD1 was purchased from Thermo Fisher
Scientific. Mouse monoclonal anti-human TARDBP
antibody (clone k1B8) was purchased from Abnova.
Anti-BiP/GRP78 was purchased from BD Transduction
Laboratories. FITC-conjugated sheep anti-mouse was
purchased from Silenus. RedDot 2 was obtained from
Biotium. Goat Anti-Rabbit IgG (H + L)-HRP Conjugate
was obtained from Bio-Rad.
Selective permeability of cells
NSC-34 cells were incubated with 20 μg/mL of biotinyl-
ated aggregated wt and G93A SOD1 in PBS for either 60
or 120 min at 37 °C. Post incubation, cells were fixed
and permeabilized with either 10 μM digitonin or 0.5 %
Triton-x100 (v/v) for either 10 or 30 min at 4 °C re-
spectively. The cells were washed three times in PBS,
blocked in 5 % BSA/PBS, for subsequent detection using
SA-Alexa 633. Cells were visualised using a TCS SP laser
scanning confocal microscopy (Leica Microsystems,
Wetzlar, Germany) using a 60x objective. The He Ne
laser (633 nm) was used and emission was collected at
645 +/− 20 nm using a standard PMT. Data were ac-
quired in Leica Application Suite (Leica Microsystems).
Cellular subfractionation
NSC-34 cells were incubated with 20 μg/mL of aggre-
gated SOD1 in PBS for 120 min at 37 °C. Post incuba-
tion the cytosolic (CEB), membrane (MEB), nuclear
(NEB) and cytoskeletal proteins (PEB) were extracted
from NSC-34 cells using a Subcellular Protein Fraction-
ation Kit for Cultured Cells (Thermo Fisher Scientific)
according to the manufacturer’s instructions. Aliquots of
cell extract (20 μg protein/lane) were separated under
reducing conditions (5 % β-mercaptoethanol) using dis-
continuous TGX Stain-Free™ Precast Gels separating
gels (BioRad). Proteins were then transferred to nitrocel-
lulose membranes (Bio-Rad, Hercules, CA) then blocked
with heat denatured casein (HDC) in PBS (pH 7.4) for
1 h at 37 °C. To detect exogenously applied SOD1, sheep
polyclonal anti-human SOD1 was used. To test the qual-
ity of the fractionation, rabbit anti-EEA1, anti- vimentin
and mouse anti- actin antibody diluted in HDC/PBS for
1 h at 37 °C were used to probe the MEB and PEB frac-
tions. Membranes were visualised using chemilumines-
cent substrate and Amersham Hyperfilm ECL (GE
Healthcare, Little Chalfont, Bukinghamshire, UK). Im-
ages of films were collected using a GS-800 Calibrated
Densitometer (Bio-Rad).
Membrane dye uptake
NSC-34 cells were treated with 20 μg/mL of soluble or ag-
gregated wt or G93A SOD1, PBS alone, or a positive con-
trol containing 200 nM PMA in PBS for 2 h at 37 °C. The
cells were then washed twice in PBS and incubated with
10 μM of FM® 1-43FX membrane stain in PBS for 7 min
at 37 °C. Excess dye was removed by several washes in
PBS and cells were returned to the incubator for 4 min.
This procedure was repeated to give a total of 8 min of in-
cubation in PBS. Post incubation, ice-cold PBS was added
to stop endocytosis and prepare cells for fixation in 4 %
(w/v) PFA/PBS (pH 7.4) for 20 min at 4 °C. Post fixation,
cells were washed twice in PBS and incubated with 1x
RedDot 2 for 10 min at RT.
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Fluid phase uptake assays
Pinocytosis involves uptake of solutes from the extracel-
lular medium. One well established solute is dextran. To
quantify the amount of fluid phase solute uptake,
NSC34 cells were treated with either 20 μg/mL of sol-
uble and biotinylated aggregated wt and G93A SOD1,
Httex146Q, α-synuclein, TDP-43, and α-lactalbumin in
PBS alone or containing 200 nM PMA for 30 min at
37 °C. Prior to harvesting or fixation, cells were incu-
bated for 15 min with 0.5 mg/ml 10 kDa 647-dextran
(Invitrogen) at 37 °C. The cells were then placed on ice
to stop dextran uptake and cells were washed three
times with ice cold PBS and once with low pH buffer
(0.1 M sodium acetate, 0.05 M NaCl, pH 5.5) for
10 min. The cells were then prepared for either flow cy-
tometry or confocal laser scanning microscopy as de-
scribed above. For flow cytometry, dextran uptake was
displayed as fluorescence mean of three or more inde-
pendent experiments.
Fixed cell antibody staining of iPSCs
The iPSCs were plated on matrigel-coated 8 mm cover-
slips at a density of 25,000 cells and cultured for 3 days
before staining. Cells were fixed with 4 % (v/v) PFA at
room temperature for 10 min, permeabilized with 0.5 %
(v/v) TritionX-100 in phosphate buffered saline (PBS)
and blocked with 5 % (w/v) bovine serum albumin
(BSA) in PBS.
The iPSC colonies were stained with Oct3/4 (mouse
1:500) (Stem Cell Technologies) primary antibody over-
night at 4C and anti-mouse Alexa Fluor 488 (1:1000)
(Life Technologies) secondary antibody for 1 h at room
temperature.
Fixed cell antibody staining of motor neurons
Cells were plated on coverslips coated with laminin
(20 μg/mL) and fibronectin (10 μg/mL) at a density of
42,000 cells/cm2. Cells were fixed using 4 % (v/v) PFA at
room temperature for 10 min. The cells were perme-
abilized with 0.5 % (v/v) Triton X-100 in PBS at room
temperature for 15 min. Cells were blocked with 5 % (w/v)
bovine serum albumin (BSA) in PBS at room temperature
for 1 h. SMI32 primary antibody (Abcam) was diluted
1:800 in PBS 5 % BSA and incubated at 4 °C overnight.
Secondary antibodies, Alexa Fluor 488 anti-sheep IgG
antibody (1:1000 in PBS 5 % BSA) was incubated with the
cells for 1 h at room temperature. Images of stained cells
were taken on a Leica DMI6000B confocal microscope
and acquired using the LAS AF 2.3.5 software.
Quantitative RT-PCR
RNA was extracted and purified from differentiated cell
using the ISOLATE II RNA Mini Kit (Bioline, USA), as
per manufacturer’s instructions. The purified RNA was
quantified using a Nanodrop 2000C (Thermo Fisher Sci-
entific, USA).
RNA was reverse transcribed into complementary
DNA (cDNA) for subsequent analysis. Reagents for
cDNA preparation were obtained from Promega (USA).
Five μg of purified RNA was annealed to random
primers (0.75 μg) and oligo dT primers (0.75 μg) by in-
cubating at 65 °C for 4 min, followed by 1 min incuba-
tion on ice. For reverse transcription, Moloney-murine
leukaemia virus reverse transcriptase (M-MLV RTase)
(150 U), 96 nmol dNTPs, RNasin (60 U) and 1x MMLV
RTase Buffer were added to the reaction mixture and
then incubated at 37 °C for 100 min.
The primers for qRT-PCR were obtained from Sigma











glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
forward: 5’-GAGCACAAGAGGAAGAGAGAGACCC-3’,
reverse: 5’-GTTGAGCACAGGGTACTTTATTGATGG
TACATG-3’. The final qRT-PCR reaction
consisted of 10 μL of SYBR Select Master Mix, 800
nM of each forward and reverse primer, 2 μL of
cDNA in a final reaction volume of 20 μL. Each
reaction was run in duplicate and a negative control
(water) and no reverse transcription (RNA) control
was included as well as a positive control using
cDNA of human putamen. The amplification
consisted of 40 cycles, of 95 °C for 15 s (activation step),
58 °C for 15 s (annealing step) and 72 °C for 1 min. A
melting curve analysis was conducted to confirm the
presence of the appropriate amplified target. The
acquired data was normalized against quantitative
expression levels of the housekeeping gene GAPDH
and analyzed using the comparative threshold cycle
method.
Preparation of giant unilamellar vesicles
The rapid evaporation method was used to prepare giant
unilamellar vesicles for confocal microscopy as described
in [36]. Briefly, soy L-α-phosphatidylcholine (Avanti
Polar Lipids Inc) was dissolved in CHCl3:MeOH (2:1) to
give a phospholipid concentration of 5 mM. Liposome
buffer (50 mM HEPES, 107 mM NaCl, 1 mM EDTA,
0.1 M sucrose, pH 7.4, 2.5 mL) was then added to the
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lipid/solvent solution in a 50 mL round bottom flask
and the two phases mixed by vigorous pipetting. The or-
ganic solvent was removed by rotary evaporator under
reduced pressure (final pressure 44 mbar) for 5 min at
35 °C. The resulting liposome suspension was stored
overnight at 4 °C prior to confocal microscopy studies.
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